- Home
- SCNX vs PMN Comparison
SCNX vs PMN Comparison
Compare SCNX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNX
- PMN
- Stock Information
- Founded
- SCNX 2010
- PMN 2004
- Country
- SCNX United States
- PMN Canada
- Employees
- SCNX N/A
- PMN N/A
- Industry
- SCNX Other Pharmaceuticals
- PMN Pharmaceuticals and Biotechnology
- Sector
- SCNX Health Care
- PMN Health Care
- Exchange
- SCNX Nasdaq
- PMN Nasdaq
- Market Cap
- SCNX 14.4M
- PMN 17.0M
- IPO Year
- SCNX 2020
- PMN N/A
- Fundamental
- Price
- SCNX $0.96
- PMN $0.49
- Analyst Decision
- SCNX
- PMN Strong Buy
- Analyst Count
- SCNX 0
- PMN 2
- Target Price
- SCNX N/A
- PMN $4.50
- AVG Volume (30 Days)
- SCNX 125.4K
- PMN 42.3K
- Earning Date
- SCNX 08-10-2025
- PMN 08-07-2025
- Dividend Yield
- SCNX N/A
- PMN N/A
- EPS Growth
- SCNX N/A
- PMN N/A
- EPS
- SCNX N/A
- PMN N/A
- Revenue
- SCNX $146,901.00
- PMN N/A
- Revenue This Year
- SCNX N/A
- PMN N/A
- Revenue Next Year
- SCNX N/A
- PMN N/A
- P/E Ratio
- SCNX N/A
- PMN N/A
- Revenue Growth
- SCNX N/A
- PMN N/A
- 52 Week Low
- SCNX $0.69
- PMN $0.47
- 52 Week High
- SCNX $23.77
- PMN $2.37
- Technical
- Relative Strength Index (RSI)
- SCNX N/A
- PMN 43.83
- Support Level
- SCNX N/A
- PMN $0.48
- Resistance Level
- SCNX N/A
- PMN $0.53
- Average True Range (ATR)
- SCNX 0.00
- PMN 0.03
- MACD
- SCNX 0.00
- PMN 0.00
- Stochastic Oscillator
- SCNX 0.00
- PMN 21.29
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.